Short Interest in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Grows By 19.4%
Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Robert Barrow Sells 25,791 Shares of Stock
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from Analysts
MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026
MindMed Announces New Employee Inducement Grant
MindMed Announces New Employee Inducement Grants
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of “Buy” from Analysts
Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript
MindMed Reports Q3 2025 Financial Results and Business Updates
MindMed to Participate in Upcoming Investor Conferences
MindMed Announces New Employee Inducement Grant
Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
MindMed Announces New Employee Inducement Grant
MindMed Nears Pivotal Year: Strong Fundamentals Make It A Buy
Mind Medicine initiated with an Outperform at LifeSci Capital
Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression
MindMed Announces New Employee Inducement Grants
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
MindMed Announces New Employee Inducement Grants
1 Reason to Buy MindMed (MNMD)
MindMed (MNMD) Q2 Net Loss Jumps 625%
Mind Medicine (MindMed) Inc. (MNMD) Q2 2025 Earnings Call Transcript
MindMed Reports Q2 2025 Financial Results and Business Updates
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy
MindMed Announces New Employee Inducement Grants
MindMed Announces New Employee Inducement Grants
Why Mind Medicine Gave Investors a Powerful Buzz in May
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade
MindMed to Participate in June Investor Conferences
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
Why Mind Medicine Stock Vaulted More Than 8% Higher Today
MindMed Announces New Employee Inducement Grants
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?
Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call Transcript
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025
MindMed Announces New Employee Inducement Grants
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
MindMed Announces New Employee Inducement Grants
Mind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call Transcript